Patent details
301033
Product Name:
Larotrectinib, desgewenst in de vorm van een farmaceutisch aanvaardbaar zout, in het bijzonder larotrectinibsulfaat, met inbegrip van larotrectinibsulfaat monohydraat
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
Ok
Cancel
You have not selected any documents
Ok
Basic Information
Publication number:
301033
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP3106463
Status:
SPC granted but not yet in force
Application number:
301033
Procedural language:
Dutch
First Applicant Residence Country:
United States of America (US)
Marketing Authorization
Marketing Authorization Number:
EU/1/19/1385
Marketing Authorization Type:
EEA
Marketing Authorization Date:
23/09/2019
Marketing Authorization Country:
European Union (EU)
Dates
Filing date:
10/03/2020
First Marketing Authorization date:
23/09/2019
Grant date:
15/04/2020
Activation date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
13/03/2020
SPC/SPC Extension Expiration Date:
22/09/2034
Lapsed By Expiration Date:
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:
Applicant/holder
From:
10/03/2020
Name:
Array Biopharma, Inc.
Address:
3200 Walnut Street, BOULDER, CO 80301, United States of America (US)
Agent
Name:
ir. M.F.J.M. Ketelaars c.s.
From:
10/03/2020
Address:
NLO
Postbus 29720, 2502 LS, Den Haag, Netherlands (NL)
To:
Publication
Bulletin
1
Bulletin Heading:
SPC
Journal edition number:
17/20
Publication date:
22/04/2020
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
2
Bulletin Heading:
SPC
Journal edition number:
12/20
Publication date:
18/03/2020
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
Annual Fee
Annual Fee(s) Due Date:
31/10/2029
Annual Fee Number:
21
Annual Fee Amount:
1600 Euro
Last Annual Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date
Document type
Document Description
Number of pages
File Type
15/04/2020
Outgoing Correspondence
Decision grant
2
PDF
/4/3/1/8/2/0800528134/docs/301033_0_338797l504a.pdf
15/04/2020
Front Page
Front Page
1
PDF
/4/3/1/8/2/0800528134/docs/301033_3_i2frontpage20200415135808258.pdf
16/03/2020
Front Page
Front Page
1
PDF
/4/3/1/8/2/0800528134/docs/301033_2_i1frontpage20200316121953445.pdf
16/03/2020
Outgoing Correspondence
Confirmation receipt request
1
PDF
/4/3/1/8/2/0800528134/docs/301033_5_331724l174.pdf
10/03/2020
SPC Documents
Summary of the characteristics of the product
21
PDF
/4/3/1/8/2/0800528134/docs/301033_1_supplprotectioncertificate20200312125947310.pdf
10/03/2020
Application Form
First filed application form
2
PDF
/4/3/1/8/2/0800528134/docs/301033_4_applicationform20200312125947007.pdf
10/03/2020
Incoming Correspondence Paper
Accompanying letter incoming document
2
PDF
/4/3/1/8/2/0800528134/docs/301033_6_incomingcorrespondencepaper20200312125947119.pdf
10/03/2020
SPC Documents
Marketing Authorization SPC
3
PDF
/4/3/1/8/2/0800528134/docs/301033_7_supplprotectioncertificate20200312125947176.pdf
10/03/2020
SPC Documents
Annex SPC
3
PDF
/4/3/1/8/2/0800528134/docs/301033_8_supplprotectioncertificate20200312125947365.pdf
10/03/2020
SPC Documents
Annex SPC
10
PDF
/4/3/1/8/2/0800528134/docs/301033_9_supplprotectioncertificate20200312125947237.pdf